[5th International Conference of FACO] FACO Session 1
09:00-09:30 Update of Oligo-BC 1 Kun Wang
(Guangdong General Hospital)
FACO Session 2 : Oral Presentation
09:30-09:40 Ectopic expression of miR-143 induces cell growth suppression and alteration of chemosensitivity in breast cancer cells Yoshihisa Tokumaru
(Gifu University School of Medicine)
09:40-09:50 Impact of uncontrolled menopause symptoms on fear of recurrence among breast cancer survivors: a prospective cohort study Im-Ryung Kim
(Samsung Medical Center)
09:50-10:00 Alternate-day versus daily administration of S-1 plus oral leucovorin with bevacizumab for refractory metastatic colorectal cancer: A comparison of two prospective studies Toshiki Masuishi
(Aichi Cancer Center Hospital)
10:00-10:10 Discussion
FACO Session 3 : Neoadjuvant Treatment of Pancreatic Cancer
10:10-10:35 Clinical outcome of Neoadjuvant Treament for borderline resectable PDAC Jin-Young Jang
(Seoul Nat'l Univ. College of Medicine)
10:35-11:00 Preoperative/Neoadjuvant Therapy in Pancreatic Cancer Jiujie Cui
(Shanghai Jiaotong Univ. School of Medicine)
11:00-11:25 Neoadjuvant Treatment of Pancreatic Cancer including conversion surgery: Collaboration study in Asia Junji Furuse
(Kyorin University Faculty of Medicine)
11:25-11:35 Chemoradiotherapy after gemcitabine plus erlotinib in patients with locally advanced pancreatic cancer Eui Kyu Chie
(Seoul National University College of Medicine)
FACO Business Meeting
14:00~15:00, Athena Room (3F)